U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
BULEVIRTIDE
USAN   INN  
Official Name English
bulevirtide [INN]
Preferred Name English
915207G
Code English
GLYCINAMIDE, N-(1-OXOTETRADECYL)GLYCYL-L-THREONYL-L-ASPARAGINYL-L-LEUCYL-L-SERYL-L-VALYL-L-PROLYL-L-ASPARAGINYL-L-PROLYL-L-LEUCYLGLYCYL-L-PHENYLALANYL-L-PHENYLALANYL-L-PROLYL-L-.ALPHA.-ASPARTYL-L-HISTIDYL-L-GLUTAMINYL-L-LEUCYL-L-.ALPHA.-ASPARTYL-L-PROLYL
Systematic Name English
HEPCLUDEX
Brand Name English
Bulevirtide [WHO-DD]
Common Name English
BULEVIRTIDE [USAN]
Common Name English
N-TETRADECANOYLGLYCYL-THR-ASN-LEU-SER-VAL-PRO-ASN-PRO-LEU-GLY-PHE-PHE-PRO-ASP-HIS-GLN-LEU-ASP-PRO-ALA-PHE-GLY-ALA-ASN-SER-ASN-ASN-PRO-ASP-TRP-ASP-PHE-ASN-PRO-ASN-LYS-ASP-HIS-TRP-PRO-GLU-ALA-ASN-LYS-VAL-GLY-NH2
Systematic Name English
MYRCLUDEX
Brand Name English
Code System Code Type Description
INN
10692
Created by admin on Tue Apr 01 22:22:10 GMT 2025 , Edited by admin on Tue Apr 01 22:22:10 GMT 2025
PRIMARY
SMS_ID
100000181745
Created by admin on Tue Apr 01 22:22:10 GMT 2025 , Edited by admin on Tue Apr 01 22:22:10 GMT 2025
PRIMARY
DRUG BANK
DB15248
Created by admin on Tue Apr 01 22:22:10 GMT 2025 , Edited by admin on Tue Apr 01 22:22:10 GMT 2025
PRIMARY
NCI_THESAURUS
C169819
Created by admin on Tue Apr 01 22:22:10 GMT 2025 , Edited by admin on Tue Apr 01 22:22:10 GMT 2025
PRIMARY
WIKIPEDIA
Bulevirtide
Created by admin on Tue Apr 01 22:22:10 GMT 2025 , Edited by admin on Tue Apr 01 22:22:10 GMT 2025
PRIMARY
USAN
JK-172
Created by admin on Tue Apr 01 22:22:10 GMT 2025 , Edited by admin on Tue Apr 01 22:22:10 GMT 2025
PRIMARY
FDA UNII
WKM56H3TLB
Created by admin on Tue Apr 01 22:22:10 GMT 2025 , Edited by admin on Tue Apr 01 22:22:10 GMT 2025
PRIMARY
CAS
2012558-47-1
Created by admin on Tue Apr 01 22:22:10 GMT 2025 , Edited by admin on Tue Apr 01 22:22:10 GMT 2025
PRIMARY
ACTIVE MOIETY
BULEVIRTIDE
SALT/SOLVATE (PARENT)
BULEVIRTIDE ACETATE
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966